If a person is losing too much weight, having bad side effects, or not seeing any benefit, the doctor may change the dose or stop the medicine
10 (October 2010): 214756
Understanding your genetic profile helps your provider decide whether temporary stopping, permanent continuation, or switching to a different compound makes most sense for your metabolism
In the PARADIGM-HF trial, among patients concurrently using MRAs, sacubitril/valsartan significantly reduced the rate of severe hyperkalemia compared with enalapril (2.2 vs
Yes, based on Phase 2 clinical trial data
Many users report a significant reduction in food noise, describing fewer intrusive thoughts about eating and a greater sense of control over daily decisions